Citations (128)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Isabella Ferreira Silva, Keiza Priscila Enes, Gustavo Machado Rocha, Fernando Pilla Varotti, Leandro Augusto Barbosa, Ralph Gruppi Thomé & Hélio Batista dos Santos. (2023) Toxicological effects of hydroxychloroquine sulfate and chloroquine diphosphate substances on the early-life stages of fish in the COVID-19 pandemic context. Journal of Environmental Science and Health, Part A 58:10, pages 825-830.
Read now
Read now
Narimana Imanova Yaghji, Elif Kilic Kan, Songul Akcan, Ramis Colak & Aysegul Atmaca. (2021) Hydroxychloroquine Sulfate Related Hypoglycemia In A Non-Diabetic COVİD-19 Patient: A Case Report and Literature Review. Postgraduate Medicine 133:5, pages 548-551.
Read now
Read now
Cassandra Doyno, Diana M. Sobieraj & William L. Baker. (2021) Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Clinical Toxicology 59:1, pages 12-23.
Read now
Read now
Mariana Babayeva & Zvi Loewy. (2020) Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine. Pharmacogenomics and Personalized Medicine 13, pages 531-542.
Read now
Read now
C. Ponticelli & G. Moroni. (2017) Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opinion on Drug Safety 16:3, pages 411-419.
Read now
Read now
Articles from other publishers (123)
Mulu Gashu, Belete Asefa Aragaw, Molla Tefera & Atakilt Abebe. (2023) Poly(bis(2,2′-bipyridine) hydroxy Copper(II) iodide modified glassy carbon electrode for electrochemical determination of chloroquine in pharmaceuticals and biological samples. Sensing and Bio-Sensing Research 42, pages 100598.
Crossref
Crossref
Liang Ee Low, Chee Kei Kong, Wei-Hsum Yap, Sangeetaprivya P. Siva, Siew Hua Gan, Wei Sheng Siew, Long Chiau Ming, Ashley Sean Lai-Foenander, Sui Kiat Chang, Wai-Leng Lee, Yongjiang Wu, Kooi-Yeong Khaw, Yong Sze Ong, Beng Ti Tey, Sachin Kumar Singh, Kamal Dua, Dinesh Kumar Chellappan & Bey-Hing Goh. (2023) Hydroxychloroquine: Key therapeutic advances and emerging nanotechnological landscape for cancer mitigation. Chemico-Biological Interactions 386, pages 110750.
Crossref
Crossref
Keisuke Kiyomiya, Ryuto Tomabechi, Naoki Saito, Kenta Watai, Tappei Takada, Yoshiyuki Shirasaka, Hisanao Kishimoto, Kei Higuchi & Katsuhisa Inoue. (2023) Macrolide and Ketolide Antibiotics Inhibit the Cytotoxic Effect of Trastuzumab Emtansine in HER2-Positive Breast Cancer Cells: Implication of a Potential Drug–ADC Interaction in Cancer Chemotherapy. Molecular Pharmaceutics.
Crossref
Crossref
Nihal A. Ibrahim, Manal A. Buabeid, El Shaimaa Arafa & Kadreya E. Elmorshedy. (2023) Zinc's protective role against hydroxychloroquine-induced cardiac effects in adult male albino rats. Saudi Journal of Biological Sciences 30:8, pages 103733.
Crossref
Crossref
Samantha X. Y. Wang, Audra Horomanski, James E. Tooley, Risheen Reejhsinghani & Andrew A. White. (2022) A change of heart. Journal of Hospital Medicine 18:5, pages 444-448.
Crossref
Crossref
Mohammad Fakhrolmobasheri, Mahnaz-Sadat HosseiniSeyedeh-Ghazal ShahrokhZahra MohammadiMohammad-Javad KahlaniSeyed-Erfan MajidiMehrdad Zeinalian. (2021) Coenzyme Q10 and Its Therapeutic Potencies Against COVID-19 and Other Similar Infections: A Molecular Review. Advanced Pharmaceutical Bulletin 13:2, pages 233-243.
Crossref
Crossref
Jessica L. Fairley, Mandana Nikpour, Heather G. Mack, Maria Brosnan, Amanda M. Saracino, Marc Pellegrini & Ian P. Wicks. (2022) How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice. Internal Medicine Journal 53:3, pages 311-317.
Crossref
Crossref
Zachary L. Cox. 2023. Managing Heart Failure in Primary Care: A Case Study Approach. Managing Heart Failure in Primary Care: A Case Study Approach
285
306
.
Zaid H. Al-Sawaff, Serap Senturk Dalgic, Fatma Kandemirli, Majid Monajjemi & Fatemeh Mollaamin. (2022) DFT Study Adsorption of Hydroxychloroquine for Treatment COVID-19 by SiC Nanotube and Al, Si Doping on Carbon Nanotube Surface: A Drug Delivery Simulation. Russian Journal of Physical Chemistry A 96:13, pages 2953-2966.
Crossref
Crossref
Khalil Saadeh, Nakulan Nantha Kumar, Ibrahim Talal Fazmin, Charlotte E. Edling & Kamalan Jeevaratnam. (2022) Anti‐malarial drugs: Mechanisms underlying their proarrhythmic effects. British Journal of Pharmacology 179:24, pages 5237-5258.
Crossref
Crossref
Luke R. Gagnon, Chandu Sadasivan, Haran Yogasundaram & Gavin Y. Oudit. (2022) Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic. Current Heart Failure Reports 19:6, pages 458-466.
Crossref
Crossref
Aurelia Magdalena Pisoschi, Florin Iordache, Loredana Stanca, Iuliana Gajaila, Oana Margarita Ghimpeteanu, Ovidiu Ionut Geicu, Liviu Bilteanu & Andreea Iren Serban. (2022) Antioxidant, Anti-inflammatory, and Immunomodulatory Roles of Nonvitamin Antioxidants in Anti-SARS-CoV-2 Therapy. Journal of Medicinal Chemistry 65:19, pages 12562-12593.
Crossref
Crossref
Lorenzo Villa Zapata, Richard D. Boyce, Eric Chou, Philip D. Hansten, John R. Horn, Sheila M. Gephart, Vignesh Subbian, Andrew Romero & Daniel C. Malone. (2022) QTc Prolongation with the Use of Hydroxychloroquine and Concomitant Arrhythmogenic Medications: A Retrospective Study Using Electronic Health Records Data. Drugs - Real World Outcomes 9:3, pages 415-423.
Crossref
Crossref
Elvira D’Andrea, Rishi J. Desai, Mengdong He, Robert J. Glynn, Hemin Lee, Michael E. Weinblatt & Seoyoung C. Kim. (2022) Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis. Journal of the American College of Cardiology 80:1, pages 36-46.
Crossref
Crossref
Beata Franczyk, Jacek Rysz, Jarosław Miłoński, Tomasz Konecki, Magdalena Rysz-Górzyńska & Anna Gluba-Brzózka. (2022) Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?. Pharmaceuticals 15:6, pages 739.
Crossref
Crossref
Emily Weidman-Evans & Mandy Porter. (2022) The cardiac effects of hydroxychloroquine in immune-mediated rheumatologic diseases. JAAPA 35:4, pages 51-53.
Crossref
Crossref
Olayinka Sunday Okoh, Nicholas Israel Nii-Trebi, Abdulrokeeb Jakkari, Tosin Titus Olaniran, Tosin Yetunde Senbadejo, Anna Aba Kafintu-kwashie, Emmanuel Oluwatobi Dairo, Tajudeen Oladunni Ganiyu, Ifiokakaninyene Ekpo Akaninyene, Louis Odinakaose Ezediuno, Idowu Jesulayomi Adeosun, Michael Asebake Ockiya, Esther Moradeyo Jimah, David J. Spiro, Elijah Kolawole Oladipo & Nídia S. Trovão. (2022) Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa. iScience 25:3, pages 103880.
Crossref
Crossref
Patrick Müller, Hannah Maus, Stefan Josef Hammerschmidt, Philip Maximilian Knaff, Volker Mailänder, Tanja Schirmeister & Christian Kersten. (2022) Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising
Therapeutic Strategy. Current Medicinal Chemistry 29:4, pages 635-665.
Crossref
Crossref
Archana Bhatia, SandeepKumar Bains, Bansal Tajinder, SSandhu Kuldeep & Jaideepa. (2022) Use of chloroquine and hydroxychloroquine in COVID-19 patients: A dilemma. Journal of Primary Care Specialties 3:1, pages 3.
Crossref
Crossref
N.A. Trofimov, V.E. Babokin, D.V. Egorov, A.V. Dubova, A.V. Nikolsky, R.G. Tabaev, A.L. Rodionov, A.G. Dragunov, O.V. Nikolaeva & S.S. Zhamlikhanova. (2022) Treatment of myocarditis in COVID-19 patients. Kardiologiya i serdechno-sosudistaya khirurgiya 15:2, pages 159.
Crossref
Crossref
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, Upadhyayula Suryanarayana Murty, Sucheta Banerjee Kurundkar, Debjani Roy, Pankaj Joshi, Dhananjay Sable, Yogendra Kumar Choudhary, Prashant Kesharwani & Amit Alexander. (2022) In-line treatments and clinical initiatives to fight against COVID-19 outbreak. Respiratory Medicine 191, pages 106192.
Crossref
Crossref
Aditi Pandey & Shivam Yadav. 2022. Data Science for COVID-19. Data Science for COVID-19
397
422
.
Pauline Byakika-Kibwika, Christine Sekaggya-Wiltshire, Jerome Roy Semakula, Jane Nakibuuka, Joseph Musaazi, James Kayima, Cornelius Sendagire, David Meya, Bruce Kirenga, Sarah Nanzigu, Arthur Kwizera, Fred Nakwagala, Ivan Kisuule, Misaki Wayengera, Henry G. Mwebesa, Moses R. Kamya & William Bazeyo. (2021) Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial. BMC Infectious Diseases 21:1.
Crossref
Crossref
Benjamin P. Geisler, Thomas C. Kingsley, Peter M. Izmirly, Nathalie Costedoat-Chalumeau & Robert O. Roswell. (2021) Hydroxychloroquine Toxicity. JCR: Journal of Clinical Rheumatology 27:8S, pages S657-S658.
Crossref
Crossref
Fariya Akter, Yusha Araf, Iftekhar Bin Naser & Salman Khan Promon. (2021) Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury. Regenerative Therapy 18, pages 447-456.
Crossref
Crossref
Urs Thomet, Bogdan Amuzescu, Thomas Knott, Stefan A. Mann, Kanigula Mubagwa & Beatrice Mihaela Radu. (2021) Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept. European Journal of Pharmacology 913, pages 174632.
Crossref
Crossref
Julianna Desmarais, James T. Rosenbaum, Karen H. Costenbader, Ellen M. Ginzler, Nicole Fett, Susan Goodman, James O’Dell, Christian A. Pineau, Gabriela Schmajuk, Victoria P. Werth, Mark S. Link & Richard Kovacs. (2021) American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity. Arthritis & Rheumatology 73:12, pages 2151-2160.
Crossref
Crossref
Thayná Rocco Machado, Mariana Martinelli Junqueira Ribeiro, Ana Carolina Rennó Sodero, Thaisa Francielle Souza Domingos, Rebeca Rapozo, Dailane Candido de Paula, Alessandra Silva Domingos, Carlos Rangel Rodrigues, Lucio Mendes Cabral, Alessandra Mendonça Teles de Souza & Bárbara de Azevedo Abrahim-Vieira. (2021) Evaluation of chloroquine and hydroxychloroquine as ACE-2 Inhibitors By In Silico Approaches: Cardiac Arrhythmia Cause?. Journal of Molecular Structure 1244, pages 130946.
Crossref
Crossref
. (2021) Hydroxychloroquine- and Azithromycin-Induced
Transient Left-Bundle Branch Block in a Patient with
COVID-19. EMJ Cardiology, pages 92-97.
Crossref
Crossref
Ahmed A. Sorour, Reto D. Kurmann, Youssef E. Shahin, Cynthia S. Crowson, Sara J. Achenbach, Rekha Mankad & Elena Myasoedova. (2021) Use of Hydroxychloroquine and Risk of Heart Failure in Patients With Rheumatoid Arthritis. The Journal of Rheumatology 48:10, pages 1508-1511.
Crossref
Crossref
Davide Villa, Gianluca Ardolino, Linda Borellini, Filippo Cogiamanian, Maurizio Vergari, Valeria Savojardo, Flora Peyvandi & Sergio Barbieri. (2021) Subclinical myopathic changes in COVID-19. Neurological Sciences 42:10, pages 3973-3979.
Crossref
Crossref
Sujan N. Agrawal. (2021) Chloroquine and Hydroxychloroquine: The History Revisited. African Journal of Biology and Medical Research 4:4, pages 1-7.
Crossref
Crossref
Takahiro Tsukimura, Tomoko Shiga, Koki Saito, Yasuhiro Ogawa, Hitoshi Sakuraba & Tadayasu Togawa. (2021) Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?. Molecular Genetics and Metabolism Reports 28, pages 100773.
Crossref
Crossref
Yan Cao, Afrasyab Khan, Samyar Zabihi & Ahmad B. Albadarin. (2021) Neural simulation and experimental investigation of Chloroquine solubility in supercritical solvent. Journal of Molecular Liquids 333, pages 115942.
Crossref
Crossref
Romain Muller. (2021) Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities. Rheumatology International 41:7, pages 1189-1202.
Crossref
Crossref
Mohammad Zaki Ahmad, Javed Ahmad, Mohammed Aslam, Mohammad Ahmed Khan, Mohammed Yahia Alasmary & Basel A Abdel-Wahab. (2021) Repurposed drug against COVID-19: nanomedicine as an approach for finding new hope in old medicines. Nano Express 2:2, pages 022007.
Crossref
Crossref
Osama A. Badary. (2021) Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs. The Pharmacogenomics Journal 21:3, pages 275-284.
Crossref
Crossref
Urooba Nadeem, Muhammad Raafey, Gene Kim, Jerermy Treger, Peter Pytel, Aliya N Husain & Jefree J Schulte. (2021) Chloroquine- and Hydroxychloroquine–Induced Cardiomyopathy: A Case Report and Brief Literature Review. American Journal of Clinical Pathology 155:6, pages 793-801.
Crossref
Crossref
Teddy S. Ehianeta, Richard O. Akinyeye, Joshua I. Orege, Onome Ejeromedoghene, Adeniyi P. Adebule & Bright O. Okonkwo. (2021) Old drugs for a new indication: a review of chloroquine and analogue in COVID-19 treatment. Porto Biomedical Journal 6:3, pages e132.
Crossref
Crossref
Gaurav Joshi, Shikha Thakur, Mayank & Ramarao Poduri. (2021) Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update. Food and Chemical Toxicology 151, pages 112106.
Crossref
Crossref
Maximilian Große, Natalia Ruetalo, Mirjam Layer, Dan Hu, Ramona Businger, Sascha Rheber, Christian Setz, Pia Rauch, Janina Auth, Maria Fröba, Ekkehard Brysch, Michael Schindler & Ulrich Schubert. (2021) Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. Viruses 13:4, pages 647.
Crossref
Crossref
MG Amer & NM Mohamed. (2021) Potential Use of Quercetin as Protective Agent against Hydroxychloroquine Induced Cardiotoxicity. Journal of Biomedical Research & Environmental Sciences 2:3, pages 185-192.
Crossref
Crossref
Adam Goldman, David Bomze, Rachel Dankner, Hanoch Hod, Tomer Meirson, Ben Boursi & Elad Maor. (2020) Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports. British Journal of Clinical Pharmacology 87:3, pages 1432-1442.
Crossref
Crossref
Stephani Correia Brazão, Lis Jappour Autran, Rosane de Oliveira Lopes, Christianne Brêtas Vieira Scaramello, Fernanda Carla Ferreira de Brito & Nadia Alice Vieira Motta. (2021) Effects of Chloroquine and Hydroxychloroquine on the Cardiovascular System - Limitations for Use in the Treatment of COVID-19. International Journal of Cardiovascular Sciences.
Crossref
Crossref
Ihunanya Chinyere Okpara & Efosa Kenneth Oghagbon. (2021) Mitigating the Risk of COVID-19 Deaths in Cardiovascular Disease Patients in Africa Resource Poor Communities. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Miguel Fogaça da Mata, Mónica Rebelo, Helena Sofia Sousa, Alexandra Rocha, Pedro Miguel, Filipa Oliveira Ramos & Patrícia Costa-Reis. (2020) Sinus node disfunction in an adolescent with systemic lupus erythematosus. Lupus 30:2, pages 342-346.
Crossref
Crossref
Serena Romani, Alexandre Gérard, Audrey Fresse, Delphine Viard, Élise Van‐Obberghen, Joëlle Micallef, Fanny Rocher & Milou‐Daniel Drici. (2020) Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic. Clinical and Translational Science 14:1, pages 163-169.
Crossref
Crossref
Debora Fedele, Antonella De Francesco, Sergio Riso & Alessandro Collo. (2021) Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview. Nutrition 81, pages 111016.
Crossref
Crossref
Mahboubeh Pishnamazi, Saber Hosseini, Samyar Zabihi, Fatemeh Borousan, Ali Zeinolabedini Hezave, Azam Marjani & Saeed Shirazian. (2021) Chloroquine (antimalaria medication with anti SARS-CoV activity) solubility in supercritical carbon dioxide. Journal of Molecular Liquids 322, pages 114539.
Crossref
Crossref
M.Y. Ansari, H.C. Ball, S.J. Wase, K. Novak & T.M. Haqqi. (2021) Lysosomal dysfunction in osteoarthritis and aged cartilage triggers apoptosis in chondrocytes through BAX mediated release of Cytochrome c. Osteoarthritis and Cartilage 29:1, pages 100-112.
Crossref
Crossref
Jeremy Y. Levett, Valeria Raparelli, Vartan Mardigyan & Mark J. Eisenberg. (2021) Cardiovascular Pathophysiology, Epidemiology, and Treatment Considerations of Coronavirus Disease 2019 (COVID-19): A Review. CJC Open 3:1, pages 28-40.
Crossref
Crossref
Pedro N. Batalha, Luana S.M. Forezi, Carolina G.S. Lima, Fernanda P. Pauli, Fernanda C.S. Boechat, Maria Cecília B.V. de Souza, Anna C. Cunha, Vitor F. Ferreira & Fernando de C. da Silva. (2021) Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches. Bioorganic Chemistry 106, pages 104488.
Crossref
Crossref
Rahul Mallick & Asim K. Duttaroy. 2021. Coronavirus Therapeutics – Volume II. Coronavirus Therapeutics – Volume II
1
22
.
Nemanja N. Muric, Nebojsa N. Arsenijevic & Milica M. Borovcanin. (2020) Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment. Frontiers in Psychiatry 11.
Crossref
Crossref
Krista L. Lentine, Ngan N. Lam, Yasar Caliskan, Tarek Alhamad, Huiling Xiao, Mark A. Schnitzler, Su‐Hsin Chang, David Axelrod, Dorry L. Segev, Mara McAdams‐DeMarco, Bertram L. Kasiske, Gregory P. Hess & Daniel C. Brennan. (2020) Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data. Clinical Transplantation 34:12.
Crossref
Crossref
Zi-Ning Lei, Zhuo-Xun Wu, Shaowei Dong, Dong-Hua Yang, Litu Zhang, Zunfu Ke, Chang Zou & Zhe-Sheng Chen. (2020) Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Pharmacology & Therapeutics 216, pages 107672.
Crossref
Crossref
Gregory L. Judson, Benjamin W. Kelemen, Joyce N. Njoroge & Vaikom S. Mahadevan. (2020) Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection. Cardiology and Therapy 9:2, pages 293-305.
Crossref
Crossref
Michael R. Massoomi, R. David Anderson, Mustafa M. Ahmed, Osama Dasa, Philip GeorgeJr.Jr., William M. Miles, Juan M. ArandaJr.Jr. & Carl J. Pepine. (2020) Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era. The American Journal of Medicine 133:11, pages 1254-1261.
Crossref
Crossref
Silvia Frattini, Gloria Maccagni, Leonardo Italia, Marco Metra & Gian B. Danzi. (2020) Coronavirus disease 2019 and cardiovascular implications. Journal of Cardiovascular Medicine 21:10, pages 725-732.
Crossref
Crossref
Lakshmi Muthukumar, Arshad Jahangir, M. Fuad Jan, Gary Neitzel, Heather Sanders, Vinay Thohan & A. Jamil Tajik. (2020) Double Jeopardy Cardiomyopathy Requiring Heart Transplant: Hydroxychloroquine and Rheumatoid Arthritis. CASE 4:5, pages 382-385.
Crossref
Crossref
Alessandra Della Porta, Kasha Bornstein, Austin Coye, Tim Montrief, Brit Long & Mehruba Anwar Parris. (2020) Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians. The American Journal of Emergency Medicine 38:10, pages 2209-2217.
Crossref
Crossref
Prashanth Kulkarni, Manjappa Mahadevappa & Srinivas Alluri. (2020) COVID-19 Pandemic and the Impact on the Cardiovascular Disease Patient Care. Current Cardiology Reviews 16:3, pages 173-177.
Crossref
Crossref
Nicholas J. White, James A. Watson, Richard M. Hoglund, Xin Hui S. Chan, Phaik Yeong Cheah & Joel Tarning. (2020) COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology. PLOS Medicine 17:9, pages e1003252.
Crossref
Crossref
Edson Silva Filho, Jairo Xavier, Leandro Cezarino, Histênio Sales & Jéssica Albuquerque. (2020) Comment on “The importance of physical exercise during the coronavirus (COVID-19) pandemic”. Revista da Associação Médica Brasileira 66:9, pages 1311-1313.
Crossref
Crossref
Yang Song & Elise Fields. (2020) Pharmacological Advances of Chloroquine and Hydroxychloroquine: From Antimalarials to Investigative Therapies in COVID-19. Natural Product Communications 15:9, pages 1934578X2095364.
Crossref
Crossref
Gelsomina Mansueto, Massimo Niola & Claudio Napoli. (2020) Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases?. Pathology - Research and Practice 216:9, pages 153086.
Crossref
Crossref
Tianxiao Liu, Songyuan Luo, Peter Libby & Guo-Ping Shi. (2020) Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients. Pharmacology & Therapeutics 213, pages 107587.
Crossref
Crossref
Mathieu Guerriaud. (2020) De la querelle du quinquina à la querelle de l’hydroxychloroquine, ou comment notre système de protection du médicament est mis à l’épreuve : une analyse historique, scientifique et juridique. Médecine & Droit 2020:163, pages 96-101.
Crossref
Crossref
Kanigula Mubagwa. (2020) Cardiac effects and toxicity of chloroquine: a short update. International Journal of Antimicrobial Agents 56:2, pages 106057.
Crossref
Crossref
Li Zou, Lijun Dai, Xingyu Zhang, Zhaohui Zhang & Zhentao Zhang. (2020) Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19. Archives of Pharmacal Research 43:8, pages 765-772.
Crossref
Crossref
Adeel S. Zubair, Lindsay S. McAlpine, Tova Gardin, Shelli Farhadian, Deena E. Kuruvilla & Serena Spudich. (2020) Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019. JAMA Neurology 77:8, pages 1018.
Crossref
Crossref
James A Watson, Joel Tarning, Richard M Hoglund, Frederic J Baud, Bruno Megarbane, Jean-Luc Clemessy & Nicholas J White. (2020) Concentration-dependent mortality of chloroquine in overdose. eLife 9.
Crossref
Crossref
Rajkumar Singh Kalra, Dhanendra Tomar, Avtar Singh Meena & Ramesh Kandimalla. (2020) SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings. Pathogens 9:7, pages 546.
Crossref
Crossref
Brit Long, William J. Brady, Alex Koyfman & Michael Gottlieb. (2020) Cardiovascular complications in COVID-19. The American Journal of Emergency Medicine 38:7, pages 1504-1507.
Crossref
Crossref
Vincenzo Russo, Roberta Bottino, Andreina Carbone, Anna Rago, Andrea Antonio Papa, Paolo Golino & Gerardo Nigro. (2020) COVID-19 and Heart: From Clinical Features to Pharmacological Implications. Journal of Clinical Medicine 9:6, pages 1944.
Crossref
Crossref
Lutfu Askin, Okan Tanrıverdi & Husna Sengul Askin. (2020) O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares. Arquivos Brasileiros de Cardiologia 114:5, pages 817-822.
Crossref
Crossref
Raquel Herrera Comoglio. (2020) I. Cloroquina / hidroxicloroquina y azitromicina. Revisión narrativa de seguridad. Latin american journal of clinical sciences and medical technology 2:2, pages 71-82.
Crossref
Crossref
Kensuke Matsushita, Benjamin Marchandot, Laurence Jesel, Patrick Ohlmann & Olivier Morel. (2020) Impact of COVID-19 on the Cardiovascular System: A Review. Journal of Clinical Medicine 9:5, pages 1407.
Crossref
Crossref
Conor J. Bloxham, Simon R. Foster & Walter G. Thomas. (2020) A Bitter Taste in Your Heart. Frontiers in Physiology 11.
Crossref
Crossref
Elissa Driggin, Mahesh V. Madhavan, Behnood Bikdeli, Taylor Chuich, Justin Laracy, Giuseppe Biondi-Zoccai, Tyler S. Brown, Caroline Der Nigoghossian, David A. Zidar, Jennifer Haythe, Daniel Brodie, Joshua A. Beckman, Ajay J. Kirtane, Gregg W. Stone, Harlan M. Krumholz & Sahil A. Parikh. (2020) Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. Journal of the American College of Cardiology 75:18, pages 2352-2371.
Crossref
Crossref
Zainab Atiyah Dakhil & Hasan Ali Farhan. (2020) Cardiovascular Impacts of COVID-19 Pandemic: From Presentation to Management: Current and Future Perspectives. Journal of Clinical and Experimental Investigations 11:3, pages em00739.
Crossref
Crossref
Niyada Naksuk, Sorin Lazar & Thoetchai (Bee) Peeraphatdit. (2020) Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. European Heart Journal: Acute Cardiovascular Care 9:3, pages 215-221.
Crossref
Crossref
Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, Sarah M Lofgren, Caleb P Skipper, Melanie R Nicol, Matthew F Pullen, Radha Rajasingham, Emily G McDonald, Todd C Lee, Ilan S Schwartz, Lauren E Kelly, Sylvain A Lother, Oriol Mitjà, Emili Letang, Mahsa Abassi & David R Boulware. (2020) Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). Open Forum Infectious Diseases 7:4.
Crossref
Crossref
Berna TERZİOĞLU BEBİTOĞLU, Elif OĞUZ, Ajla HODZİC, Nebile HATİBOĞLU & Özkan KAM. (2020) Klorokin/Hidroksiklorokin: COVID-19 tedavisi ile gündeme gelen eski bir ilaca farmakolojik bakışChloroquine / Hydroxychloroquine: Pharmacological view of an old drug currently used in COVID-19 treatment. Anadolu Kliniği Tıp Bilimleri Dergisi 25:Special Issue on COVID 19, pages 204-215.
Crossref
Crossref
Heriberto Matos Santana, Brittain Heindl, Sarabjeet Suri, Salma Khatoon, Sudeep Aryal, Arka Chatterjee, Silvio Litovsky, Hamdy Ahmed, Amanda Schnell & Indranee Rajapreyar. (2020) A Case of Heart Failure in a Patient With Systemic Lupus Erythematosus. JACC: Case Reports 2:3, pages 414-419.
Crossref
Crossref
Burkert Pieske, Carsten Tschöpe, Rudolf A. Boer, Alan G. Fraser, Stefan D. Anker, Erwan Donal, Frank Edelmann, Michael Fu, Marco Guazzi, Carolyn S.P. Lam, Patrizio Lancellotti, Vojtech Melenovsky, Daniel A. Morris, Eike Nagel, Elisabeth Pieske-Kraigher, Piotr Ponikowski, Scott D. Solomon, Ramachandran S. Vasan, Frans H. Rutten, Adriaan A. Voors, Frank Ruschitzka, Walter J. Paulus, Petar Seferovic & Gerasimos Filippatos. (2020) How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Journal of Heart Failure 22:3, pages 391-412.
Crossref
Crossref
Jelena Lewis, Tania Gregorian, Ivan Portillo & Jeff Goad. (2020) Drug interactions with antimalarial medications in older travelers: a clinical guide. Journal of Travel Medicine 27:1.
Crossref
Crossref
Milton Gorzoni. (2020) Chloroquine and hydroxychloroquine: potentially inappropriate medications for older adults?. Geriatrics, Gerontology and Aging 14:4, pages 298-302.
Crossref
Crossref
Cristiane Tavares, Rachel Emy Straus Takahashi & Carlos Viana Poyares Jardim. 2020. Clinical Synopsis of COVID-19. Clinical Synopsis of COVID-19
137
153
.
Burkert Pieske, Carsten Tschöpe, Rudolf A de Boer, Alan G Fraser, Stefan D Anker, Erwan Donal, Frank Edelmann, Michael Fu, Marco Guazzi, Carolyn S P Lam, Patrizio Lancellotti, Vojtech Melenovsky, Daniel A Morris, Eike Nagel, Elisabeth Pieske-Kraigher, Piotr Ponikowski, Scott D Solomon, Ramachandran S Vasan, Frans H Rutten, Adriaan A Voors, Frank Ruschitzka, Walter J Paulus, Petar Seferovic & Gerasimos Filippatos. (2019) How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Heart Journal 40:40, pages 3297-3317.
Crossref
Crossref
Konstantinos Tselios, Mery Deeb, Dafna D. Gladman, Paula Harvey, Shadi Akhtari, Susanna Mak, Jagdish Butany & Murray B. Urowitz. (2019) Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?. The Journal of Rheumatology 46:4, pages 391-396.
Crossref
Crossref
F R Spinelli, E Moscarelli, F Ceccarelli, F Miranda, C Perricone, S Truglia, C Garufi, L Massaro, F Morello, C Alessandri, G Valesini & F Conti. (2018) Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort. Lupus 27:10, pages 1616-1623.
Crossref
Crossref
Oded Breuer & André Schultz. (2018) Side effects of medications used to treat childhood interstitial lung disease. Paediatric Respiratory Reviews 28, pages 68-79.
Crossref
Crossref
K Tselios, D D Gladman, P Harvey, J Su & M B Urowitz. (2018) Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors. Lupus 27:9, pages 1415-1423.
Crossref
Crossref
Domenico Plantone & Tatiana Koudriavtseva. (2018) Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. Clinical Drug Investigation 38:8, pages 653-671.
Crossref
Crossref
P. Tétu, A. Hamelin, B. Lebrun-Vignes, A. Soria, A. Barbaud, C. Francès & F. Chasset. (2018) Prévalence des effets indésirables de l’hydroxychloroquine (Plaquenil ® ) dans une population dermatologique : étude rétrospective sur 102 patients. Annales de Dermatologie et de Vénéréologie 145:6-7, pages 395-404.
Crossref
Crossref
K Tselios, M Deeb, D D Gladman, P Harvey & M B Urowitz. (2017) Antimalarial-induced cardiomyopathy: a systematic review of the literature. Lupus 27:4, pages 591-599.
Crossref
Crossref
Muhammad U Dogar, Niel N Shah, Sameera Ishtiaq, Parin N Shah, Pratik Shah, Shawn Mathew & Timothy J Vittorio. (2018) Hydroxychloroquine-induced restrictive cardiomyopathy: a case report. Postgraduate Medical Journal 94:1109, pages 185-186.
Crossref
Crossref
Kwang Seob Lee, Andreas Kronbichler, Michael Eisenhut, Keum Hwa Lee & Jae Il Shin. (2018) Cardiovascular involvement in systemic rheumatic diseases: An integrated view for the treating physicians. Autoimmunity Reviews 17:3, pages 201-214.
Crossref
Crossref
Leah A. Sabato, Lisa A. Mendes & Zachary L. Cox. (2016) Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus. Journal of Pharmacy Practice 30:5, pages 571-575.
Crossref
Crossref
Amr Abdin, Janine Pöss, Reinhard Kandolf & Holger Thiele. (2016) Hydroxychloroquine-induced cardiomyopathy in a patient with limited cutaneous systemic sclerosis. Clinical Research in Cardiology 106:3, pages 234-236.
Crossref
Crossref
M. Imazio, S. Maestroni, A. Valenti, V. Ramoni & A. Brucato. 2017. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases
617
643
.
Stacey Goodman, Robert Frank Cornell, Gregg F. Rosner & Daniel S. O’Connor. 2017. Cardio-Oncology. Cardio-Oncology
125
159
.
Mauro Toledo Marrelli & Marco Brotto. (2016) The effect of malaria and anti-malarial drugs on skeletal and cardiac muscles. Malaria Journal 15:1.
Crossref
Crossref
Jason J. Kwon, Jeffrey A. Willy, Kayla A. Quirin, Ronald C. Wek, Murray Korc, Xiao-Ming Yin & Janaiah Kota. (2016) Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential. Oncotarget 7:44, pages 71635-71650.
Crossref
Crossref
Robert L. PageIIII, Cindy L. O’Bryant, Davy Cheng, Tristan J. Dow, Bonnie Ky, C. Michael Stein, Anne P. Spencer, Robin J. Trupp & JoAnn Lindenfeld. (2016) Drugs That May Cause or Exacerbate Heart Failure. Circulation 134:6.
Crossref
Crossref
Konstantinos Tselios, Dafna D. Gladman, Paula Harvey, Susanna Mak, Morel Chantal, Jagdish Butany & Murray B. Urowitz. (2016) Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus. JCR: Journal of Clinical Rheumatology 22:5, pages 287-288.
Crossref
Crossref
Nejc Pavsic, Jerca Mraz, Zvezdana Dolenc Strazar, Jasmina Gabrijelcic, Janez Toplisek, Mirta Kozelj & Katja Prokselj. (2016) Shunt reversal due to deterioration of chloroquine-induced cardiomyopathy in a patient with primary Sjögren syndrome. International Journal of Cardiology 215, pages 145-146.
Crossref
Crossref
CLOTILDE CHATRE, NATHALIE FILIPPI, FRANÇOIS ROUBILLE & YVES-MARIE PERS. (2016) Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease. The Journal of Rheumatology 43:5, pages 997-998.
Crossref
Crossref
Y. Zerbib, M.P. Guillaumont, G. Touati, P. Duhaut & J. Schmidt. (2016) Cardiotoxicité précoce de l’hydroxychloroquine. La Revue de Médecine Interne 37:3, pages 209-211.
Crossref
Crossref
Md. Abdul Alim Al-Bari. (2015) Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. Journal of Antimicrobial Chemotherapy 70:6, pages 1608-1621.
Crossref
Crossref
O. Ferraris, M. Moroso, O. Pernet, S. Emonet, A. Ferrier Rembert, G. Paranhos-Baccalà & C.N. Peyrefitte. (2015) Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules. Antiviral Research 118, pages 75-81.
Crossref
Crossref
Irene Santos-Pardo, Roger Villuendas, Iñaki Salvador-Corres, Melania Martínez-Morillo, Alejandro Olivé & Antoni Bayes-Genis. (2015) Anti-Ro/SSA antibodies and cardiac rhythm disturbances: Present and future perspectives. International Journal of Cardiology 184, pages 244-250.
Crossref
Crossref
Sarah Braun, Marion Ferner, Kai Kronfeld & Matthias Griese. (2015) Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases. Pediatric Pulmonology 50:4, pages 410-419.
Crossref
Crossref
Daniel Etxeberria-Lekuona, Conchita Ros-Martín, María Luisa Abínzano-Guillén & Ivan Méndez-López. (2015) Miocardiopatía dilatada en un paciente con lupus discoide crónico en tratamiento con mepacrina. Piel 30:3, pages 206-208.
Crossref
Crossref
E. Lazaro, C. Richez & J. Seneschal. (2015) Lupus eritematoso sistémico. EMC - Aparato Locomotor 48:1, pages 1-17.
Crossref
Crossref
Meghan A. Feely & Vincent A. De Leo. 2015. Pediatric Skin of Color. Pediatric Skin of Color
371
386
.
Ana Maria Revoredo da Silva Ventura, Tânia do Socorro Souza Chaves, Julius Caesar Mendes Monteiro, Carina Guilhon Sequeira, Maria Deise de Oliveira Ohnishi, Rosana Maria Feio Libonati, Rita Catarina Medeiros Sousa & Jose Maria de Souza. (2014) Myocarditis associated with Plasmodium vivax malaria: a case report. Revista da Sociedade Brasileira de Medicina Tropical 47:6, pages 810-813.
Crossref
Crossref
Haran Yogasundaram, Brendan N. Putko, Julia Tien, D. Ian Paterson, Bibiana Cujec, Jennifer Ringrose & Gavin Y. Oudit. (2014) Hydroxychloroquine-Induced Cardiomyopathy: Case Report, Pathophysiology, Diagnosis, and Treatment. Canadian Journal of Cardiology 30:12, pages 1706-1715.
Crossref
Crossref
Simon R. Foster, Kristina Blank, Louise E. See Hoe, Maik Behrens, Wolfgang Meyerhof, Jason N. Peart & Walter G. Thomas. (2014) Bitter taste receptor agonists elicit G‐protein‐dependent negative inotropy in the murine heart. The FASEB Journal 28:10, pages 4497-4508.
Crossref
Crossref
N. Lopez-Ruiz & C. E. Uribe. (2014) Chloroquine cardiomyopathy: beyond ocular adverse effects. Case Reports 2014:sep15 1, pages bcr2014205751-bcr2014205751.
Crossref
Crossref
Piyush Das, Abhishek Rai, Amit Chopra & Kemuel Philbrick. (2014) Psychosis Likely Induced by Hydroxychloroquine in a Patient With Chronic Q Fever: A Case Report and Clinically Relevant Review of Pharmacology. Psychosomatics 55:4, pages 409-413.
Crossref
Crossref
Oscar Ozmund Simooya. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
393
400
.